Search for Clinical Trial Results
Kidney Diseases, Cystic - 25 Studies Found
Status | Study |
Completed |
Study Name: Effect of the Aquaretic Tolvaptan on Nitric Oxide System Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2015-02-18 Interventions:
|
Recruiting |
Study Name: The German ADPKD Tolvaptan Treatment Registry Condition: ADPKD (Autosomal Dominant Polycystic Kidney Disease) Date: 2015-06-19 |
Completed |
Study Name: Clinical Implications of DNA Analysis on ADPKD Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2014-01-24 |
Enrolling by invitation |
Study Name: Open-label Trial to Evaluate the Long Term Safety of Titrated Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2014-09-25 Interventions: Drug: Tolvaptan (OPC-41061) Tolvaptan tablets (15 or 30 mg) will be self-administered orally as split-do |
Completed |
Study Name: New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease Condition:
Date: 2014-09-18 |